The pro-oncoprotein EWS (Ewing's sarcoma protein) interacts with the Brn-3a POU transcription factor and inhibits its ability to activate transcription

Cancer Biology and Therapy

Volumn 1, Issue 4, 2002, Pages 428-432

  Thomas, G Ruth ^a   Latchman, David S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bcl x; Brn 3a transcription factor; Ewing's sarcoma protein; Protein protein interaction; Transcriptional control

Indexed keywords

DNA BINDING PROTEIN; GLUTATHIONE TRANSFERASE; LUCIFERASE; POU4F1 PROTEIN, HUMAN; RNA BINDING PROTEIN EWS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR POU4; TRANSCRIPTION FACTOR POU4F1;

ARTICLE; CELL LINE; CELL TRANSFORMATION; GENETIC TRANSCRIPTION; HUMAN; METABOLISM; PROTEIN BINDING; PROTEIN SYNTHESIS; PROTEIN TERTIARY STRUCTURE; REPORTER GENE; TWO HYBRID SYSTEM;

CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; GENES, REPORTER; GLUTATHIONE TRANSFERASE; HUMANS; LUCIFERASES; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PROTEIN STRUCTURE, TERTIARY; RNA-BINDING PROTEIN EWS; TRANSCRIPTION FACTOR BRN-3; TRANSCRIPTION FACTOR BRN-3A; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 1842843228     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.1.4.23     Document Type: Article

References (41)

1. Verrijzer CP, Van der Vliet PC. POU domain transcription factors. Biochimica et Biophysica Acta 1993;1173:1-21. (Pubitemid 23125489)
2. Ryan AK, Rosenfeld MG. POU domain family values:- flexibility, partnerships and developmental codes. Genes Dev 1997; 11:1207-25. (Pubitemid 27235355)
3. He X, Treacy MN, Simmons DM, Ingraham HA, Swanson LS, Rosenfeld MG. Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 1989; 340:35-42. (Pubitemid 19172600)
4. Gerrero MR, McEvilly RJ, Turner E, Lin CR, O'Connell S, Jenne KJ, et al. Brn-3.0 A POU domain protein expressed in the sensory, immune and endocrine systems that functions on elements distinct from known octamer motifs. Proc Natl Acad Sci USA 1993; 90:10841-5. (Pubitemid 23347139)
5. Collum RG, Fisher PE, Datta M, Mellir S, Thiele C, Moroy T, et al. A novel POU homeodomain gene specifically expressed in cells of the developing nervous system. Nucleic Acids Res 1992; 20:4919-25.
6. Lillycrop KA, Budhram-Mahadeo VS, Lakin ND, Terrenghi G, Wood JN, Polak JM, et al. A novel POU family transcription factor is closely related to Brn-3 but has a distinct expression pattern in neuronal cells. Nucleic Acids Res 1992; 20:5093-6.
7. Fedtsova NG, Turner EE. Brn-3.0 expression identifies early post-mitotic CNS neurons and sensory neural precursors. Mech Dev1996; 53:291-304.
8. McEvilly RJ, Erkman L, Luo L, Sawchenko PE, Ryan AF, Rosenfeld MG, et al. Requirement for Brn-3.0 in differentiation and survival of sensory and motor neurons. Nature 1996; 384:574-7. (Pubitemid 26415936)
9. Xiang M, Gan L, Zhou L, Klein WH, Nathans J. Targeted deletion of the mouse POU domain gene Brn-3a causes a selective loss of neurons in the brainstem and trigeminal ganglion, uncoordinated limb movement, and impaired suckling. Proc Natl Acad Sci USA 1996; 93:11950-5. (Pubitemid 26347229)
10. Smith MD, Dawson SJ, Latchman DS. The Brn-3a transcription factor induces neuronal process outgrowth and the co-ordinate expression of genes encoding synaptic proteins. Mol Cell Biol 1997; 17:345-54. (Pubitemid 26425624)
11. Smith MD, Ensor EA, Coffin RS, Boxer LM, Latchman DS. Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU transcription factor. J Biol Chem 1998; 273:16715-22. (Pubitemid 28311695)
12. Ensor E, Smith MD, Latchman DS. The Brn-3a transcription factor protects sensory but not sympathetic neurones from programmed cell death/apoptosis. J Biol Chem 2001; 276: 5204-12.
13. Smith MD, Melton LA, Ensor EA, Packham G, Anderson P, Kinloch RA, et al. Brn-3a activates the expression of Bcl-XL and promotes neuronal survival in vivo as well as in vitro. Mol Cell Neurosci 2001; 17:460-70. (Pubitemid 32289849)
14. Lakin ND, Morris PJ, Theil T, Sato TN, Moroy T, Wilson MC, et al. Regulation of neurite outgrowth and SNAP-25 gene expression by the Brn-3a transcription factor. J Biol Chem 1995; 270:15858-63.
15. Smith MD, Morris PJ, Dawson SJ, Schwartz ML, Schlaepfer WW, Latchman DS. Coordinate induction of the three neurofilament genes by the Brn-3a transcription factor. J Biol Chem 1997; 272:21325-33. (Pubitemid 27374000)
16. Morris PJ, Lakin ND, Dawson SJ, Ryabanin AE, Kilimann MW, Wilson MC, et al. Differential regulation of genes encoding synaptic proteins by members of the Brn-3 sub family of POU transcription factors. Molecular Brain Research 1997; 43:279-85.
17. Morris PJ, Theil T, Ring CJA, Lillycrop KA, Möröy T, et al. The opposite and antagonistic effects of the closely related POU family transcription factors on the activity of a target promoter are dependent upon differences in the POU domain. Molecular and Cellular Biology 1994; 14:6907-14,. (Pubitemid 24299760)
18. Dawson SJ, Morris PJ, Latchman DS. A single amino acid change converts an inhibitory transcription factor into an activator. J Biol Chem 1996; 271:11631-3. (Pubitemid 26161810)
19. Morris PJ, Dawson SJ, Wilson MC, Latchman DS. A single residue within the homeodomain of the Brn-3 POU family transcription factors determines whether they activate or repress the SNAP-25 promoter. NeuroReport 1997; 8:2041-5. (Pubitemid 27314331)
20. Klemm JD, Rould MA, Aurora R, Herr W, Pabo CO. Crystal structure of the Oct-1 POU domain bound to an octamer site. DNA recognition with tethered DNA-binding molecules. Cell 1994; 77:21-23.
21. Lai J-S, Cleary MA, Herr W. A single amino acid exchange transfers VP-16 induced positive control from the Oct-1 to the Oct-2 POU homeodomain. Genes Dev 1992; 6:2058-65.
22. Pomerantz JL, Kristie TM, Sharp PA. Recognition of the surface of a homeo domain protein. Genes Dev 1992; 6:2047-57.
23. Smith MD, Dawson SJ, Boxer LM, Latchman DS. The N-terminal domain unique to the long form of the Brn-3a transcription factor is essential to protect neuronal cells from apoptosis and for the activation of Bcl-2 gene expression. Nucleic Acids Res1998; 26:4100-7.
24. Budhram-Mahadeo VS, Morris PJ, Lakin ND, Theil T, Ching GY, Lillycrop KA, et al. Activation of the --internexin promoter by the Brn-3a transcription factor is dependent on the N-terminal region of the protein. J Biol Chem 1995; 270:2853-8.
25. Budhram-Mahadeo VS, Parker M, Latchman DS. The POU Domain factors Brn-3a and Brn-3b interact with the estrogen receptor and differentially regulate transcriptional activity via an ERE. Mol Cell Biol 1998; 18:1029-41. (Pubitemid 28063437)
26. Wood JN, Bevan SJ, Coote P, Darn PM, Hogan P, Latchman DS, et al. Novel cell lines display the properties of nociceptive sensory neurons. Proceedings of the Royal Society, Series B 1990; 241:187-94. (Pubitemid 20354081)
27. Gorman CM. High efficiency gene transfer into mammalian cells. Glover DM. DNA cloning, a practical approach Vol. 2. [2], 143-190. 1985. IRL Press.
28. Smith MD, Latchman DS. The functionally antagonistic POU family transcription factors Brn-3a and Brn-3b show opposite changes in expression during the growth arrest and differentiation of human neuroblastoma cells. Int J Cancer 1996; 67:653-60. (Pubitemid 26300982)
29. Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN, Reddy ESP. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene 1994; 9:3087-97. (Pubitemid 24296791)
30. Bertolotti A, Melot T, Acker J, Vigneron M, Delattre O, Tora L. EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: Interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. Mol Cell Biol 1998; 18:1489-97. (Pubitemid 28100914)
31. Bailly R-A, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, et al. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Molecular and Cellular Biology 1994; 14:3230-41. (Pubitemid 24132736)
32. Teitell MA, Thompson AD, Sorensen PHB, Shimada H, Triche TJ, Denny CT. EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts. Lab Invest 1999; 79:1535-43. (Pubitemid 30013918)
33. Kovar H. Ewing's sarcoma and peripheral primitive neuroectodermal tumors after their genetic union. Curr Opin Oncol 1998; 10:334-42.
34. de Alava E, Gerald WL. Molecular biology of the Ewing's sarcoma/Primitive neuroectodermal tumor family. J Clin Oncol 2000; 18:204-13. (Pubitemid 30036354)
35. Li KKC, Lee KAW. Transcriptional activation by the Ewing's Sarcoma (EWS) oncogene can be cis-repressed by the RNA-binding domain. J Biol Chem 2000; 275:23053-8. (Pubitemid 30646195)
36. Bertolotti A, LutzY, Heard DJ, Chambon P, Tora L. hTAFII68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J 1996; 15:5022-31. (Pubitemid 26315812)
37. Yi H, Fujimura Y, Ouchida M. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukaemias. Oncogene 1997; 14:1259-68. (Pubitemid 27151983)
38. Tanaka K, Iwakuma T, Harimaya K, Sato H, Iwamoto Y. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. J Clin Invest 1997; 99:239-47. (Pubitemid 27053464)
39. Ouchida M, Ohno T, Fujimura Y, Rao VN, Reddy ESP. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts. Oncogene 1995; 11:1049-54.
40. Knezevich SR, Hendson G, Mathers JA, Carpenter B, Lopez-Terrada D, Brown KL, et al. Absence of detectable EWS/FLI1 expression after therapy-induced neural differentiation in Ewing sarcoma. Hum Pathol 1998; 29:289-94. (Pubitemid 28123927)
41. Thomas VD, Rorie CJ, O'Bryan JP, Chen P, Weissman BE. Suppression of neuroblastoma-specific differentiation markers and upregulation of Ewing sarcoma/peripheral primitive neuroectodermal-specific differentiation markers in neuroblastoma transfected with EWS/FLI-1 fusion gene. AACR 92nd Annual Meeting Abstract 4120. 2001.